Valuation: Amneal Pharmaceuticals, Inc.

Market Cap 7.01B 6.29B 5.75B 5.25B 9.89B 659B 10.2B 69.31B 27.64B 352B 26.33B 25.76B 1,111B P/E 2026 *
43x
P/E 2027 * 26.8x
Enterprise Value 9.33B 8.37B 7.65B 6.98B 13.15B 877B 13.56B 92.16B 36.75B 468B 35.01B 34.26B 1,477B EV / Sales 2026 *
2.9x
EV / Sales 2027 * 2.57x
Free-Float
48.38%
Yield 2026 *
-
Yield 2027 * -
1 day+3.55%
1 week-6.37%
Current month-6.37%
1 month+2.49%
3 months+11.03%
6 months+52.58%
Current year+59.84%
1 week 19.02
Extreme 19.015
20.81
1 month 18.78
Extreme 18.785
21.68
Current year 11.71
Extreme 11.71
21.68
1 year 11.38
Extreme 11.3806
21.68
3 years 3.99
Extreme 3.9912
21.68
5 years 1.24
Extreme 1.24
21.68
10 years 1.24
Extreme 1.24
24.48
Manager TitleAgeSince
Chief Executive Officer 59 2019-07-31
Chief Executive Officer 54 2019-07-31
Director of Finance/CFO 58 2023-11-06
Director TitleAgeSince
Director/Board Member 59 2023-11-06
Director/Board Member 71 2023-11-06
Director/Board Member 52 2023-11-06
Date Insider Type Main position Quantity % Market Cap. Importance
9/17/26 Don

Director

-20,445 0.0064%
9/11/26 Exercice

Director

40,890 0.0128%
9/1/26 Don

Executive/Senior Manager

-80,000 0.0251%
Change 5-day change 1-year change 3-year change Capi.($)
+3.55%-6.37%+77.13%+396.06% 7.01B
-0.79%-4.48%+46.48%+118.69% 1,206B
+1.43%+1.11%+48.05%+83.72% 665B
+1.07%-1.21%+32.92%+105.10% 515B
-0.36%-3.25%+45.42%+63.89% 381B
-0.14%-1.87%+70.06%+40.55% 362B
-0.78%-0.52%+30.47%+56.79% 307B
-0.80%-0.21%+7.98%+36.97% 289B
+0.03%-1.20%+43.79%+68.49% 249B
-0.41%-2.22%+40.43%+114.24% 207B
Average +0.28%-2.02%+44.27%+108.45% 418.68B
Weighted average by Cap. -0.04%-1.96%+42.77%+86.82%

Financials

2026 *2027 *
Net sales 3.21B 2.88B 2.63B 2.4B 4.53B 302B 4.67B 31.73B 12.65B 161B 12.05B 11.79B 508B 3.51B 3.15B 2.87B 2.62B 4.94B 330B 5.1B 34.65B 13.82B 176B 13.16B 12.88B 555B
Net income 125M 112M 103M 93.77M 177M 11.78B 182M 1.24B 494M 6.29B 470M 460M 19.84B 267M 239M 219M 200M 376M 25.07B 388M 2.64B 1.05B 13.38B 1B 980M 42.24B
Net Debt 2.31B 2.07B 1.9B 1.73B 3.26B 217B 3.36B 22.85B 9.11B 116B 8.68B 8.5B 366B 2.01B 1.8B 1.65B 1.5B 2.83B 189B 2.92B 19.83B 7.91B 101B 7.53B 7.37B 318B
Projected Income Statement - Annual - Amneal Pharmaceuticals, Inc.
Logo Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
Employees
8,700
Date Price Change Volume
26-11-06 US$20.14 +3.55% 4,725,373
26-11-05 US$19.45 -2.51% 4,948,969
26-11-04 US$19.95 -1.29% 7,234,753
26-11-03 US$20.21 -1.13% 6,440,044
26-11-02 US$20.44 -4.97% 5,019,563
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Amneal Pharmaceuticals, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
20.14USD
Average target price
24.29USD
Spread / Average Target
+20.58%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Amneal Pharmaceuticals, Inc.
  1. Stock Market
  2. Stocks
  3. AMRX Stock